Higher Accumulation of Visceral Adipose Tissue Is an Independent Risk Factor for Hepatocellular Carcinoma among Viral Hepatitis Patients with Non-Cirrhotic Livers
- PMID: 34885089
- PMCID: PMC8657094
- DOI: 10.3390/cancers13235980
Higher Accumulation of Visceral Adipose Tissue Is an Independent Risk Factor for Hepatocellular Carcinoma among Viral Hepatitis Patients with Non-Cirrhotic Livers
Abstract
This study aimed to determine the risk factors for hepatocellular carcinoma in non-cirrhotic livers among viral hepatitis patients. A total of 333 HCC cases, including 69 hepatitis B virus (HBV)-related and 264 hepatitis C virus (HCV)-related, were divided into cirrhotic (Fibrosis-4 [FIB-4] index > 3.25) and non-cirrhotic groups (FIB-4 index ≤ 3.25). The clinical characteristics of the two groups were compared. The independent risk factors for the development of HCC were analyzed using logistic regression analysis. The patients with HBV-related HCC were significantly younger, had better Child-Pugh scores, lower FIB-4 index and Mac-2 binding protein glycosylated isomers (M2BPGi) levels, more progressive cancer stage, and higher alpha-fetoprotein (AFP) levels than those with HCV-related HCC. Diabetes mellitus and hypertension were less common in patients with HBV-related HCC. The non-cirrhotic group with HBV-related HCC had a higher visceral adipose tissue index (VATI), better Child-Pugh score, and higher hemoglobin A1c (HbA1c), whereas the one with HCV-related HCC had a higher proportion of men, higher VATI, better Child-Pugh score, higher HbA1c, and a higher prevalence of hypertension, than the corresponding cirrhotic groups. Logistic regression analyses demonstrated that age, male sex, VATI, HbA1c, the presence of hypertension, and HBV etiology were independent risk factors for HCC in a non-cirrhotic liver. A high accumulation of VAT is a risk factor for HCC in patients with non-cirrhotic livers.
Keywords: hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; metabolic syndrome; visceral adipose tissue.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.Eur J Gastroenterol Hepatol. 2000 Jan;12(1):61-6. Eur J Gastroenterol Hepatol. 2000. PMID: 10656212
-
A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.Int J Epidemiol. 1998 Aug;27(4):574-8. doi: 10.1093/ije/27.4.574. Int J Epidemiol. 1998. PMID: 9758109
-
Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.Asian Pac J Cancer Prev. 2014;15(18):7563-7. doi: 10.7314/apjcp.2014.15.18.7563. Asian Pac J Cancer Prev. 2014. PMID: 25292029
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
-
Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins.Int J Mol Sci. 2021 Oct 13;22(20):11051. doi: 10.3390/ijms222011051. Int J Mol Sci. 2021. PMID: 34681709 Free PMC article. Review.
Cited by
-
NAFLD and HBV interplay - related mechanisms underlying liver disease progression.Front Immunol. 2022 Dec 5;13:965548. doi: 10.3389/fimmu.2022.965548. eCollection 2022. Front Immunol. 2022. PMID: 36544761 Free PMC article. Review.
-
Incorporating adipose tissue into a CT-based deep learning nomogram to differentiate granulomas from lung adenocarcinomas.iScience. 2024 Aug 19;27(10):110733. doi: 10.1016/j.isci.2024.110733. eCollection 2024 Oct 18. iScience. 2024. PMID: 39474083 Free PMC article.
References
LinkOut - more resources
Full Text Sources